Chairs
- Alexander Drilon (New York, NY, United States of America)
- Giuseppe Curigliano (Milan, Italy)
Introduction
Speakers
- Giuseppe Curigliano (Milan, Italy)
Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment
Speakers
- Alexander Drilon (New York, NY, United States of America)
RET fusion TKI: Present results and recent developments in Lung cancer
Speakers
- David Planchard (Villejuif, France)
RET alterations in Thyroid carcinomas: Results and recent update
Speakers
- Lori J. Wirth (Boston, MA, United States of America)
RET determination: Present recommendation of the ESMO Precision Medicine working group
Speakers
- Giuseppe Curigliano (Milan, Italy)
Conclusion: Is RET targeting ready for an agnostic use?
Speakers
- Alexander Drilon (New York, NY, United States of America)
Live Q&A
Speakers
- Giuseppe Curigliano (Milan, Italy)
- Alexander Drilon (New York, NY, United States of America)